Henriette Farkas Selected Research

Plasma Kallikrein

12/2023	Once-Daily Oral Berotralstat for Long-Term Prophylaxis of Hereditary Angioedema: The Open-Label Extension of the APeX-2 Randomized Trial.
11/2023	An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial.
6/2021	Long-term safety and effectiveness of berotralstat for hereditary angioedema: The open-label APeX-S study.
1/2021	Angioedema Without Wheals: Challenges in Laboratorial Diagnosis.
1/2021	Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial.
2/2019	Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies.
1/2018	Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Henriette Farkas Research Topics

Disease

100	Hereditary Angioedemas 04/2024 - 12/2003
37	Angioedema 02/2024 - 09/2004
14	Edema (Dropsy) 04/2024 - 12/2003
8	Rare Diseases (Rare Disease) 11/2023 - 01/2011
6	Acquired angioedema 01/2023 - 05/2006
3	Infections 11/2023 - 07/2010
3	Hypersensitivity (Allergy) 11/2023 - 01/2019
3	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 10/2011
3	Atherosclerosis 01/2019 - 04/2005
3	Neoplasms (Cancer) 03/2011 - 01/2008
2	Venous Thrombosis (Deep-Vein Thrombosis) 11/2023 - 05/2006
2	Abdominal Pain (Pain, Abdominal) 04/2023 - 01/2021
2	Inflammation (Inflammations) 04/2022 - 02/2012
2	Anaphylaxis (Anaphylactic Shock) 02/2014 - 01/2011
2	Seasonal Allergic Rhinitis (Hay Fever) 05/2003 - 08/2002
1	Inborn Genetic Diseases (Disease, Hereditary) 02/2024
1	COVID-19 11/2023
1	Urticaria (Hives) 01/2023
1	Insulin Resistance 04/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2022
1	Helicobacter Infections 04/2022
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2022
1	Erythema 06/2021
1	Vomiting 01/2021
1	Diarrhea 01/2021
1	Back Pain (Backache) 01/2021
1	Thromboembolism 03/2016
1	Polycythemia (Erythrocytosis) 02/2016
1	Cardiac Arrhythmias (Arrythmia) 01/2015

Drug/Important Bio-Agent (IBA)

25	BradykininIBA 11/2023 - 12/2011
18	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 11/2023 - 12/2003
14	Complement System Proteins (Complement)IBA 11/2023 - 06/2003
10	Danazol (Azol)FDA LinkGeneric 01/2019 - 04/2005
9	icatibantIBA 01/2021 - 08/2010
8	AntibodiesIBA 01/2023 - 01/2011
7	Plasma KallikreinIBA 12/2023 - 01/2018
7	Proteins (Proteins, Gene)FDA Link 11/2022 - 12/2003
6	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2024 - 01/2008
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2016
6	AndrogensIBA 01/2022 - 07/2010
5	Kallikreins (Kallikrein)IBA 02/2024 - 01/2018
5	berotralstatIBA 12/2023 - 01/2018
5	AutoantibodiesIBA 01/2023 - 02/2007
4	Histamine Antagonists (Antihistamines)IBA 04/2023 - 05/2003
4	Factor XII (Hageman Factor)IBA 11/2021 - 07/2010
4	conestat alfaIBA 03/2020 - 11/2008
3	C-Reactive ProteinIBA 01/2019 - 06/2003
3	Tranexamic Acid (AMCA)FDA Link 03/2016 - 08/2010
2	KininsIBA 02/2024 - 02/2019
2	sebetralstatIBA 11/2023 - 09/2023
2	GlucocorticoidsIBA 04/2023 - 01/2014
2	alpha-2-HS-GlycoproteinIBA 04/2022 - 01/2019
2	Bradykinin B2 ReceptorIBA 01/2020 - 06/2016
2	Peptides (Polypeptides)IBA 01/2020 - 01/2019
2	Serine Proteases (Serine Protease)IBA 01/2020 - 10/2015
2	Neutralizing AntibodiesIBA 01/2019 - 02/2014
2	LipidsIBA 01/2019 - 04/2005
2	Endothelin-1 (Endothelin 1)IBA 02/2016 - 02/2012
2	LectinsIBA 10/2015 - 12/2014
2	EnzymesIBA 10/2015 - 12/2014
2	Hormones (Hormone)IBA 01/2014 - 09/2004
2	Immunoglobulin G (IgG)IBA 01/2012 - 03/2011
2	Immunoglobulin M (IgM)IBA 10/2011 - 01/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2007 - 08/2002
1	Protease Inhibitors (Protease Inhibitor)IBA 04/2024
1	inter-alpha-inhibitorIBA 04/2024
1	Trypsin InhibitorsIBA 04/2024
1	VaccinesIBA 11/2023
1	Thrombin FDA Link 11/2023
1	SDMIBA 09/2023
1	Factor XIIa (Coagulation Factor XIIa)IBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	A-factor (Streptomyces)IBA 01/2023
1	PlasminogenIBA 11/2021
1	Angiopoietin-1IBA 11/2021
1	Glucosamine (Dona)IBA 11/2021
1	Heparitin Sulfate (Heparan Sulfate)IBA 11/2021
1	Complement C1 (Complement 1)IBA 08/2021
1	Interleukin-8 (Interleukin 8)IBA 06/2021
1	High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)IBA 01/2021
1	Platelet Activating FactorIBA 01/2020
1	Cholecalciferol (Vitamin D3)FDA Link 06/2019
1	lanadelumabIBA 02/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	acivicin (AT 125)IBA 01/2018
1	Secretory Phospholipases A2IBA 01/2018
1	Investigational DrugsIBA 01/2018
1	Kininogens (Kininogen)IBA 12/2017
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2017
1	Atrial Natriuretic Factor (ANF)IBA 04/2016
1	Testosterone (Sustanon)FDA Link 02/2016
1	AdrenomedullinIBA 02/2016
1	Arginine Vasopressin (Argipressin)IBA 02/2016
1	Thyroid HormonesIBA 01/2016
1	Leukocyte Elastase (Neutrophil Elastase)IBA 12/2015

Therapy/Procedure

31	Therapeutics 11/2023 - 08/2002
2	Aftercare (After-Treatment) 02/2016 - 12/2012
1	Polypharmacy 01/2020
1	Biological Therapy 01/2020
1	Oral Administration 01/2018